Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| Corrigendum: Exome Sequencing in BRCA1-2 Candidate Familias: The Contribution of Other Cancer Susceptibility Genes. | Front Oncol | 2021 | 34485163 | PubTator, text mining | PubMed |
| Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastoma. | Proc Natl Acad Sci U S A | 2021 | 34479993 | PubTator, text mining | PubMed |
| Sequence context effects of replication of Fapy•dG in three mutational hot spot sequences of the p53 gene in human cells. | DNA Repair (Amst) | 2021 | 34464900 | PubTator, text mining | PubMed |
| Update on Superficial Spindle Cell Mesenchymal Tumors in Children. | Dermatopathology (Basel) | 2021 | 34449590 | PubTator, text mining | PubMed |
| Diagnosis and management of an endometrial cancer patient with Cowden syndrome. | Gynecol Oncol | 2021 | 34446268 | PubTator, text mining | PubMed |
| Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC). | Int J Mol Sci | 2021 | 34445631 | PubTator, text mining | PubMed |
| Protective Effects of Flavonoids Against Mitochondriopathies and Associated Pathologies: Focus on the Predictive Approach and Personalized Prevention. | Int J Mol Sci | 2021 | 34445360 | PubTator, text mining | PubMed |
| The Role of DNA Damage Response in Dysbiosis-Induced Colorectal Cancer. | Cells | 2021 | 34440703 | PubTator, text mining | PubMed |
| Myofibroblasts: Function, Formation, and Scope of Molecular Therapies for Skin Fibrosis. | Biomolecules | 2021 | 34439762 | PubTator, text mining | PubMed |
| Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability. | Cancers (Basel) | 2021 | 34439310 | PubTator, text mining | PubMed |
| Recent Advances in Enhancing the Therapeutic Index of PARP Inhibitors in Breast Cancer. | Cancers (Basel) | 2021 | 34439286 | PubTator, text mining | PubMed |
| Brainstem intraparenchymal schwannoma with genetic analysis: a case report and literature review. | BMC Med Genomics | 2021 | 34407809 | PubTator, text mining | PubMed |
| Multi-syndrome, multi-gene risk modeling for individuals with a family history of cancer with the novel R package PanelPRO. | Elife | 2021 | 34406119 | PubTator, text mining | PubMed |
| Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study. | BMC Med | 2021 | 34404389 | PubTator, text mining | PubMed |
| Integrating Tumor Sequencing Into Clinical Practice for Patients With Mismatch Repair-Deficient Lynch Syndrome Spectrum Cancers. | Clin Transl Gastroenterol | 2021 | 34397043 | PubTator, text mining | PubMed |
| Cancer Genomic Profiling in Colorectal Cancer: Current Challenges in Subtyping Colorectal Cancers Based on Somatic and Germline Variants. | J Anus Rectum Colon | 2021 | 34395933 | PubTator, text mining | PubMed |
| Crosstalk between autophagy and DNA repair systems. | Turk J Biol | 2021 | 34377049 | PubTator, text mining | PubMed |
| Evaluation of global and intragenic hypomethylation in colorectal adenomas improves patient stratification and colorectal cancer risk prediction. | Clin Epigenetics | 2021 | 34372923 | PubTator, text mining | PubMed |
| Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge. | ESMO Open | 2021 | 34371384 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=61